[PDF] Top 20 Calidad del servicio y su influencia en la satisfacción de los clientes del Banco Azteca en el distrito El Porvenir - 2017
Has 10000 "Calidad del servicio y su influencia en la satisfacción de los clientes del Banco Azteca en el distrito El Porvenir - 2017" found on our website. Below are the top 20 most common "Calidad del servicio y su influencia en la satisfacción de los clientes del Banco Azteca en el distrito El Porvenir - 2017".
Scientific rationale for the possible inhaled corticosteroid intraclass difference in the risk of pneumonia in COPD
... the risk of exacerbations in COPD, but the use of ICSs is associated with increased incidence of ...the risk of pneumonia associated with fluticasone propionate and budesonide COPD ... See full document
12
The association between inhaled corticosteroid and pneumonia in COPD patients: the improvement of patients’ life quality with COPD in Taiwan (IMPACT) study
... matched risk set of that particular ...relevant risk sets, the nested case-control model is generally more efficient than a case-cohort design with the same number of selected ...is possible that the ... See full document
16
<p>Withdrawal of inhaled corticosteroids in COPD patients: rationale and algorithms</p>
... all possible clinical situations to be ...and risk of community-acquired ...stable COPD, ie, the absence of exacerbations in the previous 3 months, ... See full document
6
Risk of pneumonia with inhaled corticosteroid/long-acting β2 agonist therapy in chronic obstructive pulmonary disease: a cluster analysis
... for pneumonia (range across clusters, 4%–9%) or influenza (range ...these COPD study patients suggests a modifiable risk of pneumonia exists that can be further addressed within clinical ... See full document
12
State of progress in treating cystic fibrosis respiratory disease
... The first approved CFTR modulator, ivacaftor, is indi- cated for patients with CF with a specific mutation, G551D. This mutation results in a reduced probability of opening of the CFTR channel (an altered gating mechan- ... See full document
155
Quadrupling or quintupling inhaled corticosteroid doses to prevent asthma exacerbations: The jury's still out
... Patients: 1871 adults and adolescents (mean age 57 years) who had a diagnosis of asthma, were being treated with inhaled corticosteroid (ICS) and had had at least 1 exacerbation requiring systemic ... See full document
37
Role and rationale for the use of milnacipran in the management of fibromyalgia
... In clinical settings, however, some patients may benefit from the higher dose, as evidenced by results from the extension studies in which patients who were re-randomized to the highe[r] ... See full document
13
Factors associated with the prescription of inhaled corticosteroids in GOLD group A and B patients with COPD – subgroup analysis of the Taiwan obstructive lung disease cohort
... to COPD were collected, including age, sex, smoking history, concomitant diseases, presence of wheezing, grade and sever- ity of pulmonary function, reversibility of bronchodilator test, modified Medical Research ... See full document
19
The development of anticholinergics in the management of COPD
... Abstract: Anticholinergics have been used to treat obstructive respiratory disease for many years from historical preparations of the deadly nightshade genus, to the more recent develop- ments of ipratropium, oxitropium, ... See full document
13
Inhaled corticosteroid use in patients with chronic obstructive pulmonary disease and the risk of pneumonia: a retrospective claims data analysis
... ICS-associated pneumonia among nonselected patients with COPD may be higher than reported in controlled clinical ...to pneumonia risk in our study, again regard- less of ICS ...of COPD, ... See full document
11
Increased risk of community-acquired pneumonia in COPD patients with comorbid cardiovascular disease
... ICS-containing therapy and CVD, patients without ICS- containing therapy but with cardiovascular disease (CVD), patients with ICS-containing therapy but without CVD, and patients with ICS-containing therapy and CVD were ... See full document
47
Comparing the effectiveness of small-particle versus large-particle inhaled corticosteroid in COPD
... the COPD diagnosis was recorded at or close to the time of the asthma diagnosis for most patients, and, importantly, the COPD diagnosis was confirmed (via FEV 1 / FVC ratio ... See full document
21
Risk of pneumonia with budesonide-containing treatments in COPD: an individual patient-level pooled analysis of interventional studies
... nonfatal pneumonia SAEs and one death due to pneumonia for inhaled budesonide versus controls, with the majority of the data including only the preferred term ...163 pneumonia TESAEs, ... See full document
22
Inhaled indacaterol for the treatment of COPD patients with destroyed lung by tuberculosis and moderate-to-severe airflow limitation: results from the randomized INFINITY study
... Korean COPD patients with destroyed lung by TB and moderate-to-severe airflow ...of COPD patients with TB ...exact risk factor for COPD patients with destroyed lung by TB, the role of both ... See full document
5
A systematic review of the cardiovascular risk of inhaled anticholinergics in patients with COPD
... in COPD is the failure to collect out- come data on a strict intention-to-treat ...many COPD trials, patients’ study participation ends when the study inter- vention ... See full document
13
Inhaled corticosteroids and the risk of pneumonia in people with asthma
... We have shown that ICS are associated with an increased risk of pneumonia and LRTI in people with asthma. Our results suggest that the dose of ICS prescribed should be kept to the minimum necessary and that ... See full document
8
Biologically Active Complex for the Functional Support of the Connective Tissues: Scientific Rationale, Clinical Evidence
... Organoleptic, physical-chemical and microbiological indicators of quality and safety were investigated during the manufacturing process, and after 27 months of storage at a temperature of no higher than 25 ° C in a dry ... See full document
50
Inhaled corticosteroid normalizes some but not all airway vascular remodeling in COPD
... In summary, this longitudinal, repeat bronchoscopy study, for the first time has attempted an evaluation of the effects of ICS on airway vessel remodeling in COPD. LP, but not Rbm vessels, seem responsive to ... See full document
8
The dose of inhaled corticosteroids in patients with COPD: when less is better
... for COPD, especially in patients suffering from frequent exacerbations and in those with mixed asthma-COPD ...Increased risk of pneumonia and systemic adverse effects of ICS have generated a ... See full document
16
The analyses of risk factors for COPD in the Li ethnic group in Hainan, People’s Republic of China
... for COPD in the Li population. The risk of COPD was significantly increased with increasing number of ...the risk of COPD in group with more than five respiratory infections was 174 ... See full document
22
Related subjects